250 records found.
Dec 05, 2019
Statement from Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S.
Dec 04, 2019
Allergan Announces Positive Phase 3 ACHIEVE I Trial Results for Ubrogepant Published in The New England Journal of Medicine
Dec 03, 2019
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
Nov 22, 2019
Global Gout Disease Treatment Market to Surpass US$ 4,273.4 Million by 2027
Nov 15, 2019
Claim compensation in the Avandia drug Canada-wide settlement
Nov 05, 2019
FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations
Nov 04, 2019
Foamix Announces Publication of AMZEEQ(TM) (minocycline) Topical Foam Long Term Safety Data for Treatment Up to 1 Year in Journal of Clinical and Aesthetic Dermatology
Nov 01, 2019
Statement from Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research on new testing results, including low levels of impurities in ranitidine drugs
Oct 30, 2019
Information Update - Ranbaxy Pharmaceuticals Canada Inc. recalls prescription ranitidine products as a precaution; request to stop distribution remains in place while Health Canada continues to assess NDMA
Oct 23, 2019
Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the product
Oct 23, 2019
Duke Clinical Research Institute to Lead Pragmatic Study to Assess Effectiveness of Statins in Older Adults
Oct 18, 2019
Foamix Receives FDA Approval of AMZEEQ(TM) Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
Oct 18, 2019
Sanofi to conduct precautionary voluntary recall of Zantac OTC in Canada and the U.S.
Oct 17, 2019
Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea
Oct 10, 2019
Foamix to Present Data on its Topical Product Candidates for Acne, Rosacea at 39th Annual Fall Clinical Dermatology Conference
Oct 07, 2019
Clinician Choices Often Differ From Those of Experts When Switching HIV Treatment in Patients With Virologic Suppression
Oct 03, 2019
Medicure Announces Preferred Pricing Agreement for Zypitamag(TM) with the AIDS Drug Assistance Program ("ADAP") Crisis Task Force
Oct 03, 2019
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
Oct 03, 2019
GT Biopharma Announces HIV TriKE(TM) Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
Oct 02, 2019
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US

Pages